Clinical Trial Update: Sequential Use of Low-dose Sunitinib With Chemotherapy in Advanced NSCLC After Failure of Conventional Regimen [Phase 2]

View source ↗

Summary

This Clinical Trials update describes a Phase 2 study evaluating sequential low-dose sunitinib with chemotherapy in patients with advanced non-small cell lung c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Sutent (sunitinib)

Snippet

Sponsor: Chinese Academy of Medical Sciences | Conditions: Cancer, Lung Cancer | Phase 2 | Status: UNKNOWN